Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

New trauma treatment to be trialed by NHS

  • Comment
A cheap treatment to stem blood loss after serious injury could save thousands of lives every year and cut the need for costly and potentially risky blood transfusions.

A cheap treatment to stem blood loss after serious injury could save thousands of lives every year and cut the need for costly and potentially risky blood transfusions.

An international trial is testing the use of tranexamic acid (TXA), which is already used to stem blood loss in major surgery, in people who have sustained serious injury.

The Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage (CRASH-2) trial, which will run until 2010, is funded by the Health Technology Assessment (HTA) programme.

Involving up to 20,000 people in 47 countries, the trial aims to see whether the agent will cut the high risk of death from internal bleeding within four weeks of injury and reduce the need for blood transfusions.

The annual death toll from serious injury is around 3 million in those aged 5 to 45 around the world, many of whom die after reaching hospital.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs